Injectable obesity medications associated with reduced risk for eye inflammation
by Cleveland Clinic edited by Gaby Clark, reviewed by Robert Egan Credit: Unsplash/CC0 Public Domain Cleveland Clinic Cole Eye Institute researchers have identified a potential association between the use of GLP-1 receptor agonist (GLP-1RA) therapy and a reduced risk of non-infectious uveitis, a type of eye inflammation. Uveitis is an inflammatory eye condition that affects the uvea, the […]
Injectable obesity medications associated with reduced risk for eye inflammation Read More »
